New Capital Management LP Merck & Co., Inc. Transaction History

New Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 07, 2021	SELL	$71.68 - $78.83 $6,164 - $6,779	-86 Closed	0 $0
Q2 2020 Jul 08, 2020	SELL	$70.42 - $80.13 $3,521 - $4,006	-50 Reduced 36.76%	86 $7,000
Q1 2020 Apr 17, 2020	SELL	$63.36 - $87.82 $15,966 - $22,130	-252 Reduced 64.95%	136 $10,000
Q3 2019 Oct 09, 2019	BUY	$76.08 - $82.93 $76 - $82	1 Added 0.26%	388 $31,000
Q4 2018 Jan 18, 2019	BUY	$65.24 - $75.71 $65 - $75	1 Added 0.26%	387 $30,000
Q2 2018 Jul 09, 2018	BUY	$50.83 - $59.72 $50 - $59	1 Added 0.26%	386 $23,000
Q4 2017 Jan 19, 2018	BUY	$51.62 - $61.64 $103 - $123	2 Added 0.52%	385 $22,000
Q3 2017 Oct 23, 2017	BUY	$58.67 - $63.13 $22,470 - $24,178	383	383 $25,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of New Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on New Capital Management LP with notifications on news.